Prospective SPINE Registry
SPINE
Prospective Study on Safety and Performance of Surgalign spINE Products
1 other identifier
observational
5,000
3 countries
12
Brief Summary
This study is a prospective, multi-center, open label registry designed to collect real-world data on performance and safety data on RTI's spine products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2019
CompletedFirst Posted
Study publicly available on registry
November 25, 2019
CompletedStudy Start
First participant enrolled
January 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMarch 12, 2024
March 1, 2024
5.1 years
November 20, 2019
March 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Intervention Rates
Rates of reoperation and/or revision procedures at index level
1 month, 3 months, 6 months, 12 months, and 24 months
Secondary Outcomes (7)
Fusion
1 month, 3 months, 6 months, 12 months, and 24 months
Radiographic Findings
1 month, 3 months, 6 months, 12 months, and 24 months
Adverse Events
1 month, 3 months, 6 months, 12 months, and 24 months
Disability (Cervical)
1 month, 3 months, 6 months, 12 months, and 24 months
Disability (non-Cervical)
1 month, 3 months, 6 months, 12 months, and 24 months
- +2 more secondary outcomes
Interventions
* Interbody fusion devices - intended to help facilitate fusion by providing a platform for bone growth, while maintaining height and decompression. * Supplemental fixation and/or stabilization devices - are intended to stabilize the spine to allow for fusion to occur, maintain current spinal movement, correct deformities or curvature, treat trauma, spinal stenosis, tumor and pseudarthrosis. * Bone graft substitute - is intended to aid in fusion.
Eligibility Criteria
Patients that have spinal problems requiring treatment with an RTI Surgical spine product.
You may qualify if:
- Candidate for RTI spine product.
- Willing and able to consent to the study.
You may not qualify if:
- Patient who is, or is expected to be inaccessible for follow-up.
- Other concurrent medical or other condition (chronic or acute in nature) that in the opinion of the investigator may prevent participation or otherwise render patient ineligible for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xtant Medicallead
Study Sites (12)
Hartford Hospital
Hartford, Connecticut, 06102, United States
Florida Back Institute
Boca Raton, Florida, 33496, United States
Spine Institute of South Florida
Delray Beach, Florida, 33484, United States
Suburban Orthopaedics
Bartlett, Illinois, 60103, United States
Indiana Spine Group
Carmel, Indiana, 46032, United States
DK Orthopedics
Crown Point, Indiana, 46307, United States
Lindner Center for Research & Education at The Christ Hospit
Cincinnati, Ohio, 45219, United States
STENUM Ortho Fachklinik
Ganderkesee, 27777, Germany
Wirbelsäulenzentrum Fulda | Main | Kinzig
Gelnhausen, 63571, Germany
Katholisches Klinikum Koblenz - Montabaur
Koblenz, D-56073, Germany
St. Christopherus Krankenhaus - Katholisches Klinikum
Werne, 59368, Germany
Hospital Nacional de Parapléjicos
Toledo, 45004, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2019
First Posted
November 25, 2019
Study Start
January 28, 2020
Primary Completion
March 1, 2025
Study Completion
June 1, 2025
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD